ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Huntington's Disease Therapeutics Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-14W13789
Home | Market Reports | Health| Health Conditions
Global Huntington s Disease Therapeutics Market Research Report 2023
BUY CHAPTERS

Global Huntington's Disease Therapeutics Market Research Report 2025

Code: QYRE-Auto-14W13789
Report
September 2025
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
F.Hoffmann-La Roche
H.Lundbeck
Prana Biotechnology
Teva Pharmaceutical Industries
Horizon Pharma

Huntington's Disease Therapeutics Market Size

The global market for Huntington's Disease Therapeutics was valued at US$ 381 million in the year 2024 and is projected to reach a revised size of US$ 2305 million by 2031, growing at a CAGR of 29.8% during the forecast period.

Huntington's Disease Therapeutics Market

Huntington's Disease Therapeutics Market

Huntington"s disease is an inherited disease that causes degeneration of nerve cells in the central nervous system (CNS). The disease has a broad impact on functional abilities of the human and usually results in movement and thinking disabilities. Most people with Huntington"s disease develop signs and symptoms in their age of 30 to 40. When disease begins before age 20, the condition is known as juvenile Huntington"s disease.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Huntington's Disease Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Huntington's Disease Therapeutics.
The Huntington's Disease Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Huntington's Disease Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Huntington's Disease Therapeutics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Huntington's Disease Therapeutics Market Report

Report Metric Details
Report Name Huntington's Disease Therapeutics Market
Accounted market size in year US$ 381 million
Forecasted market size in 2031 US$ 2305 million
CAGR 29.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Antidopaminergics
  • Anticonvulsants
  • Antipsychotics
  • Antidepressants
Segment by Application
  • Hospitals
  • Clinics
  • Diagnostic Centers
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company F. Hoffmann-La Roche, H. Lundbeck, Prana Biotechnology, Teva Pharmaceutical Industries, Horizon Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Huntington's Disease Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Huntington's Disease Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Huntington's Disease Therapeutics Market growing?

Ans: The Huntington's Disease Therapeutics Market witnessing a CAGR of 29.8% during the forecast period 2025-2031.

What is the Huntington's Disease Therapeutics Market size in 2031?

Ans: The Huntington's Disease Therapeutics Market size in 2031 will be US$ 2305 million.

Who are the main players in the Huntington's Disease Therapeutics Market report?

Ans: The main players in the Huntington's Disease Therapeutics Market are F. Hoffmann-La Roche, H. Lundbeck, Prana Biotechnology, Teva Pharmaceutical Industries, Horizon Pharma

What are the Application segmentation covered in the Huntington's Disease Therapeutics Market report?

Ans: The Applications covered in the Huntington's Disease Therapeutics Market report are Hospitals, Clinics, Diagnostic Centers

What are the Type segmentation covered in the Huntington's Disease Therapeutics Market report?

Ans: The Types covered in the Huntington's Disease Therapeutics Market report are Antidopaminergics, Anticonvulsants, Antipsychotics, Antidepressants

1 Huntington's Disease Therapeutics Market Overview
1.1 Product Definition
1.2 Huntington's Disease Therapeutics by Type
1.2.1 Global Huntington's Disease Therapeutics Market Value Comparison by Type (2024 VS 2031)
1.2.2 Antidopaminergics
1.2.3 Anticonvulsants
1.2.4 Antipsychotics
1.2.5 Antidepressants
1.3 Huntington's Disease Therapeutics by Application
1.3.1 Global Huntington's Disease Therapeutics Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Centers
1.4 Global Huntington's Disease Therapeutics Market Size Estimates and Forecasts
1.4.1 Global Huntington's Disease Therapeutics Revenue 2020-2031
1.4.2 Global Huntington's Disease Therapeutics Sales 2020-2031
1.4.3 Global Huntington's Disease Therapeutics Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Huntington's Disease Therapeutics Market Competition by Manufacturers
2.1 Global Huntington's Disease Therapeutics Sales Market Share by Manufacturers (2020-2025)
2.2 Global Huntington's Disease Therapeutics Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Huntington's Disease Therapeutics Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Huntington's Disease Therapeutics, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Huntington's Disease Therapeutics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Huntington's Disease Therapeutics, Product Type & Application
2.7 Global Key Manufacturers of Huntington's Disease Therapeutics, Date of Enter into This Industry
2.8 Global Huntington's Disease Therapeutics Market Competitive Situation and Trends
2.8.1 Global Huntington's Disease Therapeutics Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Huntington's Disease Therapeutics Players Market Share by Revenue
2.8.3 Global Huntington's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Huntington's Disease Therapeutics Market Scenario by Region
3.1 Global Huntington's Disease Therapeutics Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Huntington's Disease Therapeutics Sales by Region: 2020-2031
3.2.1 Global Huntington's Disease Therapeutics Sales by Region: 2020-2025
3.2.2 Global Huntington's Disease Therapeutics Sales by Region: 2026-2031
3.3 Global Huntington's Disease Therapeutics Revenue by Region: 2020-2031
3.3.1 Global Huntington's Disease Therapeutics Revenue by Region: 2020-2025
3.3.2 Global Huntington's Disease Therapeutics Revenue by Region: 2026-2031
3.4 North America Huntington's Disease Therapeutics Market Facts & Figures by Country
3.4.1 North America Huntington's Disease Therapeutics Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Huntington's Disease Therapeutics Sales by Country (2020-2031)
3.4.3 North America Huntington's Disease Therapeutics Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Huntington's Disease Therapeutics Market Facts & Figures by Country
3.5.1 Europe Huntington's Disease Therapeutics Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Huntington's Disease Therapeutics Sales by Country (2020-2031)
3.5.3 Europe Huntington's Disease Therapeutics Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Huntington's Disease Therapeutics Market Facts & Figures by Region
3.6.1 Asia Pacific Huntington's Disease Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Huntington's Disease Therapeutics Sales by Region (2020-2031)
3.6.3 Asia Pacific Huntington's Disease Therapeutics Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Huntington's Disease Therapeutics Market Facts & Figures by Country
3.7.1 Latin America Huntington's Disease Therapeutics Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Huntington's Disease Therapeutics Sales by Country (2020-2031)
3.7.3 Latin America Huntington's Disease Therapeutics Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Huntington's Disease Therapeutics Market Facts & Figures by Country
3.8.1 Middle East and Africa Huntington's Disease Therapeutics Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Huntington's Disease Therapeutics Sales by Country (2020-2031)
3.8.3 Middle East and Africa Huntington's Disease Therapeutics Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Huntington's Disease Therapeutics Sales by Type (2020-2031)
4.1.1 Global Huntington's Disease Therapeutics Sales by Type (2020-2025)
4.1.2 Global Huntington's Disease Therapeutics Sales by Type (2026-2031)
4.1.3 Global Huntington's Disease Therapeutics Sales Market Share by Type (2020-2031)
4.2 Global Huntington's Disease Therapeutics Revenue by Type (2020-2031)
4.2.1 Global Huntington's Disease Therapeutics Revenue by Type (2020-2025)
4.2.2 Global Huntington's Disease Therapeutics Revenue by Type (2026-2031)
4.2.3 Global Huntington's Disease Therapeutics Revenue Market Share by Type (2020-2031)
4.3 Global Huntington's Disease Therapeutics Price by Type (2020-2031)
5 Segment by Application
5.1 Global Huntington's Disease Therapeutics Sales by Application (2020-2031)
5.1.1 Global Huntington's Disease Therapeutics Sales by Application (2020-2025)
5.1.2 Global Huntington's Disease Therapeutics Sales by Application (2026-2031)
5.1.3 Global Huntington's Disease Therapeutics Sales Market Share by Application (2020-2031)
5.2 Global Huntington's Disease Therapeutics Revenue by Application (2020-2031)
5.2.1 Global Huntington's Disease Therapeutics Revenue by Application (2020-2025)
5.2.2 Global Huntington's Disease Therapeutics Revenue by Application (2026-2031)
5.2.3 Global Huntington's Disease Therapeutics Revenue Market Share by Application (2020-2031)
5.3 Global Huntington's Disease Therapeutics Price by Application (2020-2031)
6 Key Companies Profiled
6.1 F. Hoffmann-La Roche
6.1.1 F. Hoffmann-La Roche Company Information
6.1.2 F. Hoffmann-La Roche Description and Business Overview
6.1.3 F. Hoffmann-La Roche Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.1.4 F. Hoffmann-La Roche Huntington's Disease Therapeutics Product Portfolio
6.1.5 F. Hoffmann-La Roche Recent Developments/Updates
6.2 H. Lundbeck
6.2.1 H. Lundbeck Company Information
6.2.2 H. Lundbeck Description and Business Overview
6.2.3 H. Lundbeck Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.2.4 H. Lundbeck Huntington's Disease Therapeutics Product Portfolio
6.2.5 H. Lundbeck Recent Developments/Updates
6.3 Prana Biotechnology
6.3.1 Prana Biotechnology Company Information
6.3.2 Prana Biotechnology Description and Business Overview
6.3.3 Prana Biotechnology Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Prana Biotechnology Huntington's Disease Therapeutics Product Portfolio
6.3.5 Prana Biotechnology Recent Developments/Updates
6.4 Teva Pharmaceutical Industries
6.4.1 Teva Pharmaceutical Industries Company Information
6.4.2 Teva Pharmaceutical Industries Description and Business Overview
6.4.3 Teva Pharmaceutical Industries Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Teva Pharmaceutical Industries Huntington's Disease Therapeutics Product Portfolio
6.4.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.5 Horizon Pharma
6.5.1 Horizon Pharma Company Information
6.5.2 Horizon Pharma Description and Business Overview
6.5.3 Horizon Pharma Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Horizon Pharma Huntington's Disease Therapeutics Product Portfolio
6.5.5 Horizon Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Huntington's Disease Therapeutics Industry Chain Analysis
7.2 Huntington's Disease Therapeutics Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Huntington's Disease Therapeutics Production Mode & Process Analysis
7.4 Huntington's Disease Therapeutics Sales and Marketing
7.4.1 Huntington's Disease Therapeutics Sales Channels
7.4.2 Huntington's Disease Therapeutics Distributors
7.5 Huntington's Disease Therapeutics Customer Analysis
8 Huntington's Disease Therapeutics Market Dynamics
8.1 Huntington's Disease Therapeutics Industry Trends
8.2 Huntington's Disease Therapeutics Market Drivers
8.3 Huntington's Disease Therapeutics Market Challenges
8.4 Huntington's Disease Therapeutics Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
F.Hoffmann-La Roche
H.Lundbeck
Prana Biotechnology
Teva Pharmaceutical Industries
Horizon Pharma
List of Tables
 Table 1. Global Huntington's Disease Therapeutics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Huntington's Disease Therapeutics Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Huntington's Disease Therapeutics Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Huntington's Disease Therapeutics Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Huntington's Disease Therapeutics Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Huntington's Disease Therapeutics Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Huntington's Disease Therapeutics Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Huntington's Disease Therapeutics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Huntington's Disease Therapeutics, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Huntington's Disease Therapeutics, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Huntington's Disease Therapeutics, Product Type & Application
 Table 12. Global Key Manufacturers of Huntington's Disease Therapeutics, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Huntington's Disease Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Huntington's Disease Therapeutics as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Huntington's Disease Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Huntington's Disease Therapeutics Sales by Region (2020-2025) & (K Units)
 Table 18. Global Huntington's Disease Therapeutics Sales Market Share by Region (2020-2025)
 Table 19. Global Huntington's Disease Therapeutics Sales by Region (2026-2031) & (K Units)
 Table 20. Global Huntington's Disease Therapeutics Sales Market Share by Region (2026-2031)
 Table 21. Global Huntington's Disease Therapeutics Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Huntington's Disease Therapeutics Revenue Market Share by Region (2020-2025)
 Table 23. Global Huntington's Disease Therapeutics Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Huntington's Disease Therapeutics Revenue Market Share by Region (2026-2031)
 Table 25. North America Huntington's Disease Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Huntington's Disease Therapeutics Sales by Country (2020-2025) & (K Units)
 Table 27. North America Huntington's Disease Therapeutics Sales by Country (2026-2031) & (K Units)
 Table 28. North America Huntington's Disease Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Huntington's Disease Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Huntington's Disease Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Huntington's Disease Therapeutics Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Huntington's Disease Therapeutics Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Huntington's Disease Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Huntington's Disease Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Huntington's Disease Therapeutics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Huntington's Disease Therapeutics Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Huntington's Disease Therapeutics Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Huntington's Disease Therapeutics Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Huntington's Disease Therapeutics Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Huntington's Disease Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Huntington's Disease Therapeutics Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Huntington's Disease Therapeutics Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Huntington's Disease Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Huntington's Disease Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Huntington's Disease Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Huntington's Disease Therapeutics Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Huntington's Disease Therapeutics Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Huntington's Disease Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Huntington's Disease Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Huntington's Disease Therapeutics Sales (K Units) by Type (2020-2025)
 Table 51. Global Huntington's Disease Therapeutics Sales (K Units) by Type (2026-2031)
 Table 52. Global Huntington's Disease Therapeutics Sales Market Share by Type (2020-2025)
 Table 53. Global Huntington's Disease Therapeutics Sales Market Share by Type (2026-2031)
 Table 54. Global Huntington's Disease Therapeutics Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Huntington's Disease Therapeutics Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Huntington's Disease Therapeutics Revenue Market Share by Type (2020-2025)
 Table 57. Global Huntington's Disease Therapeutics Revenue Market Share by Type (2026-2031)
 Table 58. Global Huntington's Disease Therapeutics Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Huntington's Disease Therapeutics Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Huntington's Disease Therapeutics Sales (K Units) by Application (2020-2025)
 Table 61. Global Huntington's Disease Therapeutics Sales (K Units) by Application (2026-2031)
 Table 62. Global Huntington's Disease Therapeutics Sales Market Share by Application (2020-2025)
 Table 63. Global Huntington's Disease Therapeutics Sales Market Share by Application (2026-2031)
 Table 64. Global Huntington's Disease Therapeutics Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Huntington's Disease Therapeutics Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Huntington's Disease Therapeutics Revenue Market Share by Application (2020-2025)
 Table 67. Global Huntington's Disease Therapeutics Revenue Market Share by Application (2026-2031)
 Table 68. Global Huntington's Disease Therapeutics Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Huntington's Disease Therapeutics Price (USD/Unit) by Application (2026-2031)
 Table 70. F. Hoffmann-La Roche Company Information
 Table 71. F. Hoffmann-La Roche Description and Business Overview
 Table 72. F. Hoffmann-La Roche Huntington's Disease Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. F. Hoffmann-La Roche Huntington's Disease Therapeutics Product
 Table 74. F. Hoffmann-La Roche Recent Developments/Updates
 Table 75. H. Lundbeck Company Information
 Table 76. H. Lundbeck Description and Business Overview
 Table 77. H. Lundbeck Huntington's Disease Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. H. Lundbeck Huntington's Disease Therapeutics Product
 Table 79. H. Lundbeck Recent Developments/Updates
 Table 80. Prana Biotechnology Company Information
 Table 81. Prana Biotechnology Description and Business Overview
 Table 82. Prana Biotechnology Huntington's Disease Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Prana Biotechnology Huntington's Disease Therapeutics Product
 Table 84. Prana Biotechnology Recent Developments/Updates
 Table 85. Teva Pharmaceutical Industries Company Information
 Table 86. Teva Pharmaceutical Industries Description and Business Overview
 Table 87. Teva Pharmaceutical Industries Huntington's Disease Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Teva Pharmaceutical Industries Huntington's Disease Therapeutics Product
 Table 89. Teva Pharmaceutical Industries Recent Developments/Updates
 Table 90. Horizon Pharma Company Information
 Table 91. Horizon Pharma Description and Business Overview
 Table 92. Horizon Pharma Huntington's Disease Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Horizon Pharma Huntington's Disease Therapeutics Product
 Table 94. Horizon Pharma Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Huntington's Disease Therapeutics Distributors List
 Table 98. Huntington's Disease Therapeutics Customers List
 Table 99. Huntington's Disease Therapeutics Market Trends
 Table 100. Huntington's Disease Therapeutics Market Drivers
 Table 101. Huntington's Disease Therapeutics Market Challenges
 Table 102. Huntington's Disease Therapeutics Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Huntington's Disease Therapeutics
 Figure 2. Global Huntington's Disease Therapeutics Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Huntington's Disease Therapeutics Market Share by Type: 2024 & 2031
 Figure 4. Antidopaminergics Product Picture
 Figure 5. Anticonvulsants Product Picture
 Figure 6. Antipsychotics Product Picture
 Figure 7. Antidepressants Product Picture
 Figure 8. Global Huntington's Disease Therapeutics Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Huntington's Disease Therapeutics Market Share by Application: 2024 & 2031
 Figure 10. Hospitals
 Figure 11. Clinics
 Figure 12. Diagnostic Centers
 Figure 13. Global Huntington's Disease Therapeutics Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Huntington's Disease Therapeutics Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Huntington's Disease Therapeutics Sales (2020-2031) & (K Units)
 Figure 16. Global Huntington's Disease Therapeutics Average Price (USD/Unit) & (2020-2031)
 Figure 17. Huntington's Disease Therapeutics Report Years Considered
 Figure 18. Huntington's Disease Therapeutics Sales Share by Manufacturers in 2024
 Figure 19. Global Huntington's Disease Therapeutics Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Huntington's Disease Therapeutics Players: Market Share by Revenue in Huntington's Disease Therapeutics in 2024
 Figure 21. Huntington's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Huntington's Disease Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Huntington's Disease Therapeutics Sales Market Share by Country (2020-2031)
 Figure 24. North America Huntington's Disease Therapeutics Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Huntington's Disease Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Huntington's Disease Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Huntington's Disease Therapeutics Sales Market Share by Country (2020-2031)
 Figure 28. Europe Huntington's Disease Therapeutics Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Huntington's Disease Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Huntington's Disease Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Huntington's Disease Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Huntington's Disease Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Huntington's Disease Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Huntington's Disease Therapeutics Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Huntington's Disease Therapeutics Revenue Market Share by Region (2020-2031)
 Figure 36. China Huntington's Disease Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Huntington's Disease Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Huntington's Disease Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Huntington's Disease Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Huntington's Disease Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Huntington's Disease Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Huntington's Disease Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Huntington's Disease Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Huntington's Disease Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Huntington's Disease Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Huntington's Disease Therapeutics Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Huntington's Disease Therapeutics Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Huntington's Disease Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Huntington's Disease Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Huntington's Disease Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Huntington's Disease Therapeutics Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Huntington's Disease Therapeutics Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Huntington's Disease Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Huntington's Disease Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Huntington's Disease Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Huntington's Disease Therapeutics by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Huntington's Disease Therapeutics by Type (2020-2031)
 Figure 58. Global Huntington's Disease Therapeutics Price (USD/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Huntington's Disease Therapeutics by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Huntington's Disease Therapeutics by Application (2020-2031)
 Figure 61. Global Huntington's Disease Therapeutics Price (USD/Unit) by Application (2020-2031)
 Figure 62. Huntington's Disease Therapeutics Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32P14840
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Digital Platform for Chronic Kidney Disease (CKD) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20V18395
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Continuous Glucose Monitoring Sensor Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32G20014
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Radioactive Iodine Ablation Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9U20281
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions